Artiva Biotherapeutics, Inc.'s total assets for Q3 2024 were $225.60M, an increase of 197.18% from the previous quarter. ARTV total liabilities were $24.60M for the fiscal quarter, a -90.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.